AIEgen-biomacromolecule conjugates: Visualized delivery and light-controlled theranostic platforms DOI

Siqin Chen,

Bowen Li, Bin Liu

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 378, С. 605 - 618

Опубликована: Дек. 25, 2024

Язык: Английский

Nitric Oxide-Producing Multiple Functional Nanoparticle Remodeling Tumor Microenvironment for Synergistic Photodynamic Immunotherapy against Hypoxic Tumor DOI
Shuyu Xu, Xinxin Xie, Ping He

и другие.

ACS Nano, Год журнала: 2025, Номер unknown

Опубликована: Фев. 6, 2025

The treatment of pancreatic cancer faces significant challenges due to connective tissue hyperplasia and severe hypoxia. Unlike oxygen-dependent Type II photosensitizers, I photosensitizers can produce a substantial amount reactive oxygen species, even under hypoxic conditions, making them more suitable for photodynamic therapy cancer. However, the dense extracellular matrix limits penetration efficiency presence immunosuppressive cells in tumor microenvironment reduces therapeutic effect. To address these challenges, we designed photoimmunotherapeutic M1@PAP nanoparticles composed photosensitizer anti-PD-L1 siRNA (siPD-L1), which was encapsulated into M1 macrophage membrane vesicles. In this system, pyropheophorbide-a (PPA) covalently conjugated poly-l-arginine (Arg9). Notably, it capable generating sufficient superoxide anions thereby functioning as photosensitizer. Furthermore, Arg9 acted nitric oxide (NO) donor, enhancing nanophotosensitizer by inhibiting cancer-associated fibroblast (CAF) activation decomposing matrix. Additionally, vesicles provided active targeting capabilities reeducated immunosuppressed M2 macrophages. reversal further promoted efficacy immunotherapy, showing great potential synergistic immunotherapy against tumor.

Язык: Английский

Процитировано

2

Homologous-adhering/targeting cell membrane- and cell-mediated delivery systems: a cancer-catch-cancer strategy in cancer therapy DOI Creative Commons
Chenguang Liu, Jingjie Gao, Yuying Cheng

и другие.

Regenerative Biomaterials, Год журнала: 2024, Номер 12

Опубликована: Ноя. 20, 2024

Abstract Low tumor enrichment remains a serious and urgent problem for drug delivery in cancer therapy. Accurate targeting of sites is still critical aim Though there have been variety strategies to improve the enrichment, biological barriers cause most delivered guests fail or be excreted before they work. Recently, cell membrane-based systems attracted huge amount attention due their advantages such as easy access, good biocompatibility immune escape, which contribute biomimetic structures specific surface proteins. Furthermore, are referred homologous-targeting function exhibit significantly high adhesion internalization homologous-type cells even though exact mechanism not entirely revealed. Here, we summarize sources characterizations membrane systems, including reconstructed single hybrid nano-/microcarriers, well engineered cells. Additionally, advanced applications these therapy categorized summarized according components membranes. The potential factors related homologous also discussed. By discussing applications, challenges opportunities, expect far-reaching development preclinic clinics.

Язык: Английский

Процитировано

4

Hyaluronic acid-mediated targeted nano-modulators for activation of pyroptosis for cancer therapy through multichannel regulation of Ca2+ overload DOI
Linwei Li,

Zihan Xing,

Jinyu Wang

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер 299, С. 140116 - 140116

Опубликована: Янв. 20, 2025

Язык: Английский

Процитировано

0

Hyperthermia-Accelerated Ion-Radical Production for Enhanced Tumor Nanocatalytic Therapy with Inhibition of Tumor Growth and Recurrence DOI
Wenlong Liu, Haoran Li,

Yuan Huo

и другие.

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer DOI Creative Commons
Liming Gong, Heming Zhao, Liqing Chen

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(2), С. 246 - 246

Опубликована: Фев. 13, 2025

Background: Colorectal cancer (CRC) is one of the common malignant tumors. Chemotherapeutic agents represented by doxorubicin (DOX) are adjuvant therapies for patients with advanced CRC. However, DOX suffers from dose-dependent cardiotoxicity and myelosuppression due to a lack targeting specificity, which severely limits its clinical application. Methods: Herein, we constructed zeolitic imidazolate framework-8 (ZIF-8) modified novel peptide (LT peptide) deliver chemotherapeutic drug targeted treatment Results: In this study, LT-PEG@DOX@ZIF-8 nanoparticles were prepared simple method suitable particle size zeta potential, also capable pH-responsive release. vitro assays exhibited that effectively taken up C26 cells, significantly inhibited cell proliferation, induced apoptosis. Furthermore, in mice models colorectal tumors, displayed specific tumor aggregation exerted anti-tumor effects prolong survival mice. Conclusions: conclusion, provides promising strategy delivery treat

Язык: Английский

Процитировано

0

A magnetic nanoreactor with microenvironment regulation capability for targeted and enhanced tumor chemodynamic therapy DOI
Xin Li, Qing Tang, Monica Tang

и другие.

Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 161356 - 161356

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Prominent Supramolecular Systems for Cancer Therapy: From Structural Design to Tailored Applications DOI
Jiawei Zhang, Qingya Zhang,

LI Xiao-jia

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2025, Номер unknown, С. 117754 - 117754

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0

Chemodynamic Therapy Enhanced 131I‐Radiotherapy for Efficient Inhibition on Cancer Growth and Metastasis DOI

Caiting Deng,

Jingjing Zhang, Yuchen Yang

и другие.

Small, Год журнала: 2025, Номер unknown

Опубликована: Май 16, 2025

Abstract Iodine‐131 ( 131 I), a cornerstone of thyroid cancer therapy, suffers from limited efficacy in other cancers due to poor tumor accumulation and hypoxia‐driven radiotherapy resistance. To overcome these challenges, I‐M@HI, theranostic nanoparticle was engineered that synergizes with chemodynamic therapy (CDT). This platform integrated Mn(III) porphyrin indocyanine green self‐assembled on albumin, enabling dual‐mode fluorescence/MRI‐guided imaging, tumor/sentinel lymph node‐targeted accumulation, hypoxia modulation. The catalyzes intratumoral hydrogen peroxide into cytotoxic hydroxyl radicals for CDT while alleviating amplify I radiotherapy. In subcutaneous tumors, I‐M@HI achieved >85% inhibition by inducing immunogenic cell death, marked calreticulin exposure high mobility group box 1 release, triggered systemic anti‐tumor immunity. Strikingly, breast metastasis model, selectively eradicated sentinel node metastases, reducing lung metastatic nodules >90%, representing critical advancement preventing spread. work pioneers multifunctional nanoplatform not only enhances but also redefines precision inhibition, offering transformative strategy advanced therapy.

Язык: Английский

Процитировано

0

Green-Reduced Biodegradable Core–Shell Smart-Responsive MOFs for Photothermal-Enhanced Chemo–Chemodynamic in Tumor Catalysis Therapy DOI
Lai Wei, Yimei Zhang, Xiaole Yin

и другие.

Molecular Pharmaceutics, Год журнала: 2025, Номер unknown

Опубликована: Май 17, 2025

Metal-organic frameworks (MOFs) have been widely developed for the treatment of malignant tumors due to their high porosity, ease functionalization, and smart-responsive degradation. Herein, a core-shell nanocomposite PAZDH (HA@DOX-PDA@Bio-Ag/ZIF-8) based on polydopamine (PDA)-coated green-reduced silver nanoparticles (Bio-Ag NPs) loaded zeolite imidazolium framework-8 (ZIF-8) is designed, which can trigger near-infrared light (NIR)-enhanced chemodynamic reaction chemotherapy effective tumor treatment. Due targeting shell CD44 receptor, overexpressed in cells, NPs actively aggregate at site. Subsequently, pH-sensitive degradation core, this release Bio-Ag doxorubicin (DOX) manner. Moreover, prepared by method using plant extract particle size 40 nm, easily enter cells endocytosis induce apoptosis catalyzing production cytotoxic ·OH from H2O2 enriched TME. Importantly, temperature generated PTT promote DOX accelerate generation rate ·OH, enabling photothermal-enhanced chemo-chemodynamic therapy. The efficiently ablation inhibit solid up 91.72%. In conclusion, study provides promising strategy development MOFs field

Язык: Английский

Процитировано

0

NIR‐II‐Responsive Chainmail Nanocatalysts for Spatiotemporally Controlled Enzymatic Tumor Therapy DOI
Hongji Liu, Zhen‐Xing Wang, Xinyue Hu

и другие.

Advanced Healthcare Materials, Год журнала: 2025, Номер unknown

Опубликована: Май 20, 2025

Abstract The clinical translation of metal‐based peroxidase‐like nanozymes for antitumor therapy faces two critical challenges: off‐target catalytic activation and suboptimal hydroxyl radical (•OH) generation efficiency. To address these limitations, an innovative chainmail nanocatalyst featuring nitrogen‐doped carbon‐encapsulated nanoceria is developed, which combines spatial confinement effects with photo‐trigger enhancement. graphitic carbon shell serves as a physical barrier that effectively isolates metallic cerium from the biological environment, reducing nonspecific by 100% compared to bare nanoceria. Remarkably, under 1064 nm laser irradiation, electrons species can penetrate through quantum tunneling effects, activating multiple enzymatic pathways. Vacancy engineering further optimizes Ce 3+ /Ce 4+ redox pair ratio (1.75 vs 0.44 in pristine nanoceria), establishing electron reservoir facilitates amplification H 2 O ‐to‐•OH conversion glutathione oxidase‐mimicking activity tumor microenvironment remodeling. This dual mechanism synergistically elevates intracellular oxidative stress while preserving normal tissue viability. In vivo evaluations demonstrate photoactivated exhibits remarkable suppression efficacy, prolonging survival duration tumor‐bearing mice 33 days 70 days. light‐gated architecture provides paradigm spatiotemporally controlled therapy, resolving dilemma between potency specificity nanozyme design.

Язык: Английский

Процитировано

0